Details of the Drug Formulations
General Information of Drug (ID: DMG3Y89)
Drug Name | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | Ecteinascidin; Ecteinascidin-743; Et-743; Yondelis (TN) | |||||||||||||||||||||||||||||||
Indication |
|
|||||||||||||||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||||||||||||||
Full List of Drug Formulations Containing This Drug
References
1 | Trabectedin FDA Label | ||||
---|---|---|---|---|---|
2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2774). | ||||
3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | ||||